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Inhibition of mammalian DNA topoisomerase I by phospholipids was investigated using purified enzyme. Acidic phospholipids inhibited the DNA 
relaxation activity of topoisomerase I whereas neutral phospholipid, phosphatidylethanolamine, didnot. Accumulation of a protein-DNA cleavable 
complex, an intermediate which is known to accumulate upon inhibition by a specific inhibitor camptothecin, did not occur. The filter binding 
assay revealed that the DNA binding activity of the enzyme was inhibited by acidic phospholipids. Moreoever, direct binding of phosphatidylglycer- 
01 to topoisomerase I was demonstrated. These results indicated that the inhibitory effect of acidic phospholipids on topoisomerase I was due to 
the loss of the DNA binding of the enzyme as a result of direct interaction between phospholipids and the enzyme. 
Topoisomerase I; Phospholipid 
1. INTRODUCTION 
Recently eukaryotic DNA topoisomerase I has been 
considered to have an important function in replica- 
tion, transcription and recombination [l-7]. The en- 
zyme catalyzes topological alterations in DNA by 
introducing a transient single-strand break through 
which another DNA strand can pass [l]. 
Several lines of evidence suggest that active 
chromatin may exist in a dynamic, tortionally stressed 
state [1,2]. The degree of DNA supercoiling in 
chromatin probably controlled by balancing the relaxa- 
tion activity of DNA topoisomerase I and the recently 
discovered supercoiling activity of DNA topoisomerase 
II assisted by ‘supercoiling factor’ [8,9]. A correlation 
between the proliferation state of eukaryotic cells and 
DNA superhelicity has been observed by several in- 
vestigators [lo-121. From the point of view described 
above, regulation of topoisomerase I activity may 
represent one possible mechanism of regulating cellular 
proliferation. Regulation of topoisomerase I activity in 
vivo is still unclear although post-translational 
modifications such as poly(ADP-ribosylation) [ 13,141 
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and phosphorylation [ 15,161 were found to modulate 
topoisomerase I activity in vitro. 
Recently, Umekawa et al. reported that phospho- 
lipids inhibit in vitro replication of an autonomous 
replicating sequence presumably due to the inhibition 
of topoisomerase I activity in the nuclear extract [ 171. 
Using purified topoisomerase I, we report here that the 
inhibition of topoisomerase I by acidic phospholipids is 
due to direct binding of phospholipids to the enzyme 
resulting in the inhibition of the DNA binding of 
topoisomerase I. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cardiolipin (CL; bovine heart), phosphatidylserine (PS; bovine 
spinal cord), phosphatidylinositol (PI; wheat germ), phosphatidyl- 
glycerol (PG; egg lecithin) and phosphatidylethanolamine (PE; egg 
yolk) were purchased from Lipid Products (England). Phospholipids 
were vacuum-dried to form Alms on the bottom of glass tubes and 
suspended in distilled water by vigorous vortex mixing. PE was 
suspended in 0.05% Triton X-100. Camptothecin (CPT) was ob- 
tained from Yakult Honsha Co. 
Topoisomerase I was purified from mouse Ehrlich ascites tumor 
cells as described [18] with some modifications. 3’-End labeling of 
EcoRI-restricted ColEl DNA with [w”‘P]~ATP was performed as 
described [19]. 
2.2. DNA relaxation and cleavable cotnplw formation assays 
DNA relaxation activity of topoisomerase I was assayed essentially 
as described previously [18]. The reaction mixture contained in a total 
volume of 40~1 0.3 cg supercoiled ColEl DNA, 50 mM NaCl, 
50 mM Tris-HCl @H 7.5), 10% glycerol, 50rg/ml BSA, 1 mM 
EDTA and topoisomerase I (3 units, 10 ng) with or without 
phospholipid or CPT. The mixture was incubated at 37°C for 
15 min. One unit of the enzyme is defined as the minimum amount 
of enzyme giving complete relaxation of 0.3 gg supercoiled ColEl 
Pubttihed by EIsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/%3.50 0 1990 Federation f European Biochemical Societies 151 
Volume 261, number 1 FEBS LETTERS 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2425 26 27 
February 1990 
Fig. 1. Inhibition of DNA relaxation activity of topoisomerase I by phospholipids. Phospholipids used were CL (lanes 3-6), PE (lanes 7-lo), 
PC (lanes ll-14), PS (lanes 15-l@, PI (lanes 19-22). Phospholipids were added at concentrations of 2 fiM (lanes 3, 7, 11, 15 and 19), 10 ,uM 
(lanes 4, 8, 12, 16 and 20), 50pM (lanes 5, 9, 13, 17 and 21) and 100,uM (lanes 6, 10, 14, 18 and 22). (Lanes 23-27) Reactions without 
topoisomerase I in the presence of phospholipids (lane 23, CL; lane 24, PE; lane 25, PC; lane 26, PS; lane 27, PI). (Lane 1) ColEl DNA only; 
and (lane 2) ColEl DNA and topoisomerase I. I and Ir represent supercoiled form I DNA and relaxed form I DNA, respectively. 
DNA under the conditions used. Cleavable complex formation bet- 
ween DNA and topoisomerase I in the presence of CPT or 
phospholipids was assayed as described by Hsiang et al. [20] except 
that 30 units (100 ng) topoisomerase I and 0.3 pg DNA were used. 
2.3. Filter binding assay 
[‘*PI-ColEl DNA (1 ng) and 25 ng topoisomerase I were mixed in 
4081 binding buffer (10 mM Tris-HCl, pH 7.5, 20pg/ml BSA and 
0.1 mM EDTA) with or without phospholipids and incubated for 
10 min at 0°C and then filtered through a nitrocellulose membrane 
(Toyo Roshi, 0.2pm). The DNA-protein complexes trapped were 
washed with 3 ml binding buffer. The bound radioactivity was 
measured by a liquid scintillation counter. 
2.4, Binding analysis of topokomerase I to phospholipids 
Phospholipid (100 cg) and topoisomerase I (0.5 /rg) were mixed in 
40 pl buffer (10 mM Tris-HCl, pH 7.5, 150 pg/ml BSA and 100 mM 
NaCl) and then centrifuged at 1000 x g for 10 min at 4°C. The 
precipitate was then dissolved in 10 ~1 SDS-sample buffer (0.1 M 
dithiothreitol, 2% SDS, 0.08 M Tris-HCl, pH 6.8, 150/o glycerol and 
0.006070 bromophenol blue) and analyzed by SDS-polyacrylamide gel 
electrophoresis as described [21]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the effect of various phospholipids on 
the relaxation activity of purified mouse topoisomerase 
I. Relaxation assays were carried out as described in 
section 2. From the extent of relaxed molecules, the 
doses giving 50% inhibition (ID5o) were estimated as 
follows: 4 pM for CL and PG, 10 FM for PI, 30 pM for 
123456789 
PS and > 100 /cM for PE. CL and PG showed stronger 
inhibitory effect than PI and PS did. On the contrary, 
PE showed no effect. The inhibitory concentrations of 
phospholipids were surprisingly similar to that of CPT 
(5 PM), a specific inhibitor of mammalian topo- 
isomerase I (data not shown). These results indicate 
that the inhibition of topoisomerase I by phospholipids 
is quite potent and significant. The inhibitory effect of 
phospholipids may well be due to the interaction with 
the enzyme rather than with the substrate, since 
phospholipid itself had no effect on the supercoiled 
DNA judged from their mobilities (fig. 1, lanes 23-27). 
Inhibitory concentrations of phospholipids were well 
consistent with those of Umekawa et al. [17], although 
they used crude nuclear extracts as a source of 
topoisomerase I. 
The catalytic process by DNA topoisomerase I might 
be divided into 4 steps: (i) DNA binding, (ii) single- 
strand cleavage, (iii) strand passage, and (iv) DNA 
resealing [l]. To know which step(s) is inhibited by 
phospholipids, we performed an analysis to detect an 
intermediate cleavable complex which is known to be 
accumulated upon inhibition by camptothecin (CPT) 
[20]. In this experiment a 10 times greater amount of 
enzyme was used in order to detect the intermediates 
clearly, so the inhibitory effect of phospholipids was 
relatively weak as shown in fig.2 compared to that 
10 Ii 12 13 14151617 
Fig.2. Detection of cleavable complexes accumulated by phospholipids and CPT. Phospholipids or CPT were added at doses of 10 PM (lanes 
3, 6, 9, 12 and 15), 50pM (lanes 4, 7, 10, 13 and 16) and 150pM (lanes 5, 8, 11, 14 and 17). (Lanes 3-5) CL; (lanes 6-8) PC; (lanes 9-11) 
PS; (lanes 12-14) PI; (lanes 15-17) CPT. (Lane 1) ColEl DNA and topoisomerase I. (Lane 2) ColEl DNA only. I and Ir are described in fig. 1. 
II indicates the position of nicked circular DNA (form II). 
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Fig.3. (a) Nitrocellulose filter assay for binding of enzyme to DNA. Each point shows the average of triplicate reactions. Bars indicate SD. The 
input count of DNA was about 10000 cpm (-1 ng). (b) Effect of phospholipids on DNA binding of topoisomerase I. Each point represents the 
average of two assays. CL (0). PG (o), PS (O), PE (m), PI (v). 
shown in fig. 1. Cleavable complexes formed in in vitro 
reactions with phospholipids were analyzed by an 
agarose gel electrophoresis containing 0.25 pg/ml 
ethidium bromide where relaxed form I DNA is 
distinguished from nicked circular form II DNA. There 
were no significant accumulations of intermediate form 
II DNA for all phospholipids tested (fig.2, lanes 3-14) 
whereas CPT caused the accumulation (fig.2, lanes 
15-17). PE did not show any effect on the intermediate 
accumulation as well as on the DNA relaxation (data 
not shown). These results indicate that phospholipids 
inhibit topoisomerase I reaction by some other 
mechanism distinct from that of CPT which stabilizes 
intermediates. 
Next, we tested an inhibitory effect of phospholipids 
on the DNA binding activity of topoisomerase I by the 
filter binding assay [23]. Fig.3a shows a typical profile 
of an effect of increasing concentrations of enzyme on 
the binding. Fig.3b shows the effect of phospholipids 
on this assay. Twenty-five ng of topoisomerase I and 
32P-labeled ColEl DNA (1 ng) were mixed with or 
without phospholipids and then DNA-protein com- 
plexes were trapped on the filter. All phospholipids, ex- 
cept PE, inhibited the binding of topoisomerase I to 
DNA. PI was the most effective, and CL and PG were 
more effective than PS. PE showed no effect as it had 
done on the relaxation assay. The extent of inhibitory 
activities of phospholipids on the DNA binding of 
topoisomerase I correlated fairly well with those on the 
relaxation activity. This strongly suggests that acidic 
phospholipids inhibit the DNA binding step of 
topoisomerase I. 
To demonstrate more directly whether phospholipids 
interact with topoisomerase I, we carried out the ex- 
periment as follows. Purified topoisomerase I (0.5 ,ug) 
was mixed with PG or PE vesicles (100 pug each) and 
then the phospholipid vesicles were recovered by cen- 
trifugation. Topoisomerase I bound to phospholipid 
vesicles was analyzed by SDS-polyacrylamide gel elec- 
trophoresis. Fig.4 shows that only in the case of PG 
vesicles, topoisomerase I was recovered in the 
precipitate (fig.4, lane 2). This result indicates that PG 
interacts with topoisomerase I directly resulting in in- 
hibition of DNA binding, presumably due to masking 
of DNA binding site(s) of the enzyme. Although we 
have not carried out the assay for other acidic 
phospholipids, the situation might be the same. 
Ml 234 
-Topo I 
Fig.4. Binding of topoisomerase I to phospholipid vesicles. (Lane 1) 
Without phospholipids; (lane 2) phosphatidylglycerol vesicles; (lane 
3) phosphatidylethanolamine v sicles; (lane 4) 0.5 fig purified mouse 
topoisomerase I; (lane M) marker proteins with molecular masses in 
kilodaltons. 
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The present report demonstrates that inhibition of 
eukaryotic topoisomerase I by acidic phospholipids is 
mediated by direct interaction between the enzyme and 
phospholipids. This direct interaction may well be due 
to an electrostatic interaction between acidic 
phospholipid and basic protein topoisomerase I with a 
pl of 8.4 [24]. It is of relevance to refer to the inhibition 
of the enzyme by acidic polysaccharide-like heparin 
[22]. Although it is not known whether phospholipids 
interact with topoisomerase I in vivo, it is tempting to 
speculate that the activity of topoisomerase I localized 
in nuclei [25] is modulated by interacting with 
phospholipids, one of the components of nuclear mem- 
brane [26]. If this was the case, changes of nuclear 
phospholipid composition coupled with cellular 
physiological changes might control the activity of the 
enzyme. This may then lead to the alteration of the ac- 
tivity of chromatin, i.e. transcription, replication, etc. 
This might, in turn, affect the cellular proliferation and 
differentiation. 
Recently involvement of phospholipids in DNA 
replication and transcription of both eukaryotic and 
prokaryotic systems have been suggested [27-301 (Hirai 
et al., unpublished). Regulation of nuclear enzymes by 
phospholipids might be ubiquitous and important as 
well as transmembrane signaling that is known to be 
regulated by phospholipid metabolites [3 11. 
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